PGC-1α alternative promoter (Exon 1b) controls augmentation of total PGC-1α gene expression in response to cold water immersion and low glycogen availability.
CWI
Exon
PGC-1α
Journal
European journal of applied physiology
ISSN: 1439-6327
Titre abrégé: Eur J Appl Physiol
Pays: Germany
ID NLM: 100954790
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
18
03
2020
accepted:
04
08
2020
pubmed:
26
8
2020
medline:
30
7
2021
entrez:
26
8
2020
Statut:
ppublish
Résumé
This investigation sought to determine whether post-exercise cold water immersion and low glycogen availability, separately and in combination, would preferentially activate either the Exon 1a or Exon 1b Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) promoter. Through a reanalysis of sample design, we identified that the systemic cold-induced augmentation of total PGC-1α gene expression observed previously (Allan et al. in J Appl Physiol 123(2):451-459, 2017) was largely a result of increased expression from the alternative promoter (Exon 1b), rather than canonical promoter (Exon 1a). Low glycogen availability in combination with local cooling of the muscle (Allan et al. in Physiol Rep 7(11):e14082, 2019) demonstrated that PGC-1α alternative promoter (Exon 1b) expression continued to rise at 3 h post-exercise in all conditions; whilst, expression from the canonical promoter (Exon 1a) decreased between the same time points (post-exercise-3 h post-exercise). Importantly, this increase in PGC-1α Exon 1b expression was reduced compared to the response of low glycogen or cold water immersion alone, suggesting that the combination of prior low glycogen and CWI post-exercise impaired the response in gene expression versus these conditions individually. Data herein emphasise the influence of post-exercise cooling and low glycogen availability on Exon-specific control of total PGC-1 α gene expression and highlight the need for future research to assess Exon-specific regulation of PGC-1α.
Identifiants
pubmed: 32840695
doi: 10.1007/s00421-020-04467-6
pii: 10.1007/s00421-020-04467-6
pmc: PMC7560925
doi:
Substances chimiques
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
0
Water
059QF0KO0R
Glycogen
9005-79-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2487-2493Références
J Mol Endocrinol. 2015 Oct;55(2):159-68
pubmed: 26293291
Diabetologia. 2015 Sep;58(9):1969-77
pubmed: 26109214
Physiol Rep. 2019 Jun;7(11):e14082
pubmed: 31161726
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21401-6
pubmed: 19966219
Med Sci Sports Exerc. 2014 Oct;46(10):1900-7
pubmed: 24561815
Am J Physiol Endocrinol Metab. 2018 Jan 1;314(1):E1-E20
pubmed: 28874356
Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E341-9
pubmed: 21098736
Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1092-8
pubmed: 21862727
J Appl Physiol (1985). 2017 Aug 1;123(2):451-459
pubmed: 28546467
Eur J Appl Physiol. 2016 Dec;116(11-12):2315-2326
pubmed: 27699485
Biomed Res Int. 2014;2014:402175
pubmed: 25136584
Sports Med. 2018 May;48(5):1031-1048
pubmed: 29453741
Physiol Rep. 2015 Oct;3(10):
pubmed: 26438733
Med Sci Sports Exerc. 2009 Jan;41(1):3-13
pubmed: 19092709
Acta Naturae. 2015 Jan-Mar;7(1):48-59
pubmed: 25927001
J Appl Physiol (1985). 2019 Jun 1;126(6):1587-1597
pubmed: 31046515
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
J Biol Chem. 2016 Jul 15;291(29):15169-84
pubmed: 27231350
Physiol Rep. 2013 Nov;1(6):e00140
pubmed: 24400142